Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
MEMORY PHARMACEUTICALS CORP (MEMY) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/12/2009 CT ORDER Form CT ORDER -- Confidential treatment order
01/09/2009 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/07/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-06 Registration Form: POS AM Reference AccNo: 0000950123-09-000106
01/07/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-06 Registration Form: POS AM Reference AccNo: 0000950123-09-000105
01/06/2009 8-K Quarterly results
01/06/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/06/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/06/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/06/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/06/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/06/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/06/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/06/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/06/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/02/2009 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
12/29/2008 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
12/24/2008 8-K Form 8-K -- Current report
12/19/2008 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
12/19/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Memory Pharmaceuticals Reports Phase 1 Data for R4996/MEM 63908"
12/18/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Memory Pharmaceuticals Initiates Phase 2a Trial for MEM 1414 in Asthma"
12/16/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement"
12/15/2008 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
12/15/2008 SC 13D/A MPM BioVentures IV QP LP has filed a Schedule 13D for Memory Pharmaceuticals Corp.
12/05/2008 SC 13D/A MEMORY PHARMACEUTICALS CORP has filed a Schedule 13D for Memory Pharmaceuticals Corp.
12/04/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Memory Pharmaceuticals Receives NASDAQ Decisions"
11/25/2008 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Hoffmann-La Roche Inc., 900 North Point Acquisition Corporation, and Memory Pharmaceuticals Corp",
"Form of Stockholder Tender and Support Agreement, by and among each of the individuals or entities listed on the signature page thereto and Roche",
"Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals"
11/20/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated with Schizophrenia"
11/14/2008 10-Q Quarterly Report for the period ended September 30, 2008
11/13/2008 TRN Memory Pharmaceuticals Corp. Q3 2008 Earnings Call Transcript
11/13/2008 8-K Quarterly results
Docs: "Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results"
11/03/2008 8-K Form 8-K -- Current report
10/28/2008 8-K Form 8-K -- Current report
10/27/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Memory Pharmaceuticals Announces Issuance of Key U.S. Patent for R3487/MEM 3454 and R4996/MEM 63908"
09/26/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy